Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
This is a high-stakes scenario requiring immediate, coordinated action balancing legal, ethical, financial, and reputational considerations. Here’s a detailed hour-by-hour plan for the next 48 hours, along with the reasoning behind each step: Hour 0-1: Immediate Response & Executive Alignment Convene Emergency…Read the full answer
As CEO, I would not wait six months and I would not let the board delay disclosure while patients remain exposed to an unreported serious risk. I would treat this as a patient-safety, regulatory, legal, and trust crisis—not merely a financial-risk issue. My guiding decisions would be: Patient safety comes first.Read the full answer